1125 Intratumoral administration of SARS-CoV-2 reduces tumor progression and alters the tumor immune microenvironment similar to that of the seasonal influenza vaccine | Zendy

AI Assistant Blog Pricing

1125 Intratumoral administration of SARS-CoV-2 reduces tumor progression and alters the tumor immune microenvironment similar to that of the seasonal influenza vaccine

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.